FDA Inspection 1028050 — Vitalant

Vitalant — FEI 1642797

The FDA completed an inspection of Vitalant on July 18, 2017 in Roswell, NM. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 18, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Roswell, NM (United States)